A suite of new studies links popular weight-loss and diabetes drugs to lower cancer risks and better outcomes for those with the disease, though researchers say more research is needed
A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but […]





